Mengdi Chen
197 Ruijin Er Road
Huangpu, 200025, China
Huangpu, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal Breast Cancer: A Single-Arm Clinical Trial.
Journal: International journal of cancer
Published: June 10, 2025
Tertiary lymphoid structures signature predicts prognosis and clinical benefits from neoadjuvant chemotherapy and PD-1 blockade in colorectal adenocarcinoma.
Journal: International journal of surgery (London, England)
Published: January 21, 2025
Super-enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5-FU Resistance in Gastric Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 02, 2024
SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer.
Journal: EBioMedicine
Published: February 20, 2024
Editorial: New insights into molecular mechanisms and targeted therapy for gastrointestinal tumors.
Journal: Frontiers in cell and developmental biology
Published: September 06, 2023
BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 14, 2023
A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Journal: Frontiers in immunology
Published: February 27, 2023
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: February 07, 2022
Impact of Different Modules of 21-Gene Assay in Early Breast Cancer Patients.
Journal: Frontiers in endocrinology
Published: August 16, 2021
Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
Journal: Clinical breast cancer
Published: December 28, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026